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Objective: The aim of this study is to present the incidence, prenatal and postnatal ﬁndings, and modes of
ascertainment in chromosomal deletions detected at amniocentesis.
Materials and methods: We reviewed all the cases with chromosomal deletions, which were detected by
amniocentesis in Mackay Memorial Hospital, Taipei, Taiwan, between January 1987 and December 2012.
Data on the locations and types of deletion, reasons for performing amniocentesis, maternal age,
gestational age at amniocentesis, fetal karyotypes, inheritance of deletions, and relative prenatal ﬁndings
were collected.
Results: Amniocentesis was performed in 33,305 cases within this period of time. Among these, 31 cases
of chromosomal deletions were considered for the study. The mean gestational age at amniocentesis was
21.0 weeks (range from 15 weeks to 32 weeks) and the mean maternal age at amniocentesis was 32.1
years (range from 26 years to 37 years). Nineteen cases (61.3%) manifested fetal structural abnormalities
on ultrasound, nine (29.0%) presented no ultrasound abnormalities, and three had an unknown status.
The main modes of ascertainment included abnormal ultrasound ﬁndings in 10 cases (32.2%), advanced
maternal age in 11 cases (35.5%), abnormal maternal serum screening results in six cases (19.6%), and
other reasons in four cases (13.0%). Of the 27 cases with known inheritance, the deletion was inherited in
two (6.6%) and de novo in 25 (92.6%). Males accounted for 11 (35.5%) and females for 20 (64.5%) cases.
Chromosomal deletions are more often to occur in chromosomal 5(4 cases, 12.9%), chromosomal 18 (4
cases, 12.9%), chromosomal 4 (3 cases, 9.7%), chromosomal 7 (3 cases, 9.7%), chromosomal 10 (3 cases,
9.7%), chromosomal 11 (3 cases, 9.7%), and chromosomal 1 (2 cases, 6.5%). There were four cases of
chromosomal mosaicism: two involved chromosome 5, one involved chromosome 10, and one involved
chromosome 18. Twenty-three cases (74.2%) had terminal deletions and the other eight cases (26.7%) had
interstitial-type deletions.
Conclusion: In summary, we have presented the results of prenatal diagnosis for chromosomal deletions
using amniocentesis. Chromosomal deletions are more likely to occur in females and more often in
chromosomal 5p and 18q. Prenatal diagnosis at amniocentesis is frequently associated with advanced
maternal age, abnormal ultrasound ﬁndings, and abnormal maternal serum screening. The frequency of
ascertainment in chromosome deletion seems to be directly correlated with advanced maternal age and
abnormal ultrasound ﬁndings. In cases with terminal deletions, prenatal ultrasound plays a more
important role for prenatal diagnosis.
Copyright  2014, Taiwan Association of Obstetrics & Gynecology. Published by Elsevier Taiwan LLC. All
rights reserved.nd Gynecology, Mackay Memorial Hospital, 92, Section 2, Chung-San North Road, Taipei, Taiwan.
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Prenatal diagnosis with amniocentesis had been performed for
many decades, and various types of chromosomal abnormalities
were reported in several references. Deletion of a chromosome is a
kind of structural aberration, which means that a portion of the
chromosome is missing or deleted. There are two types of de-
letions: when a deletion occurs toward the end of a chromosome,
we call it a “terminal deletion” and when it occurs from the interior
of a chromosome, we call it an “interstitial deletion”. The symbol
del is used to denote these deletions. Amniocentesis may detect
inherited or de novo deletions. The loss of genetic materials may
cause different kinds of fetal anomalies. In this article, we present
cases of chromosomal deletion from our cytogenetic laboratory in
Mackay Memorial Hospital, Taipei, Taiwan.Materials and methods
We reviewed all the cases with chromosomal deletions, which
were detected by amniocentesis in Mackay Memorial Hospital,
between January 1987 and December 2012. Data on the locations
and types of deletion, reasons for performing amniocentesis,
maternal age, gestational age at amniocentesis, fetal karyotypes,
inheritance of deletions, and relative prenatal ﬁndings were
collected. Cytogenetic analyses of parental blood lymphocytes were
performed in all cases. The clinical data of our study cases are
summarized in Table 1 [1e19].Results
Within this period of time, amniocentesis was performed in
33,305 cases. Various kinds of chromosomal abnormalities were
found in 967 cases; the incidence of chromosomal abnormality was
3.1%. Among these, 31 cases of chromosomal deletions were stud-
ied. The incidence of chromosomal deletion was 0.093% (about 1/
1110). It accounts for only 3.2% of total chromosomal abnormalities
observed by us.
Of these cases, the mean gestational age at amniocentesis was
21.0 weeks (range from 15 weeks to 32 weeks) and the mean
maternal age at amniocentesis was 32.1 years (range from 26 years
to 37 years). Of the 31 cases, 19 cases (61.3%) manifested fetal
structural abnormalities on ultrasound, nine (29.0%) presented no
ultrasound abnormalities, and three had an unknown status. The
main modes of ascertainment included abnormal ultrasound
ﬁndings in 10 cases (32.2%), advanced maternal age in 11 cases
(35.5%), abnormal maternal serum screening results in six cases
(19.6%), and other reasons in four cases (13.0%).
Of the 27 cases with known inheritance, the deletion was
inherited in two (6.6%) and de novo in 25 (92.6%). Males accounted
for 11 cases (35.5%) and females for 20 cases (64.5%). Chromosomes
involved in the greatest proportion of deletions were chromosome
5 (4 cases, 12.9%), chromosome 18 (4 cases, 12.9%), chromosome 4
(3 cases, 9.7%), chromosome 7 (3 cases, 9.7%), chromosome 10 (3
cases, 9.7%), chromosome 11 (3 cases, 9.7%), and chromosome 1 (2
cases, 6.5%).
Four cases of chromosomal mosaicism were recorded: two
involved chromosome 5, one involved chromosome 10, and one
involved chromosome 18.
Twenty-three cases (74.2%) had terminal deletions and the other
eight cases (26.7%) had interstitial-type deletions. Among the cases
of terminal deletion, 16 (16/23, 69.6%) manifested fetal structural
abnormalities on prenatal ultrasound, whereas four (4/8, 50%)
accounted for interstitial deletion.Discussion
The ﬁrst domestic study of amniocentesis in Taiwan was re-
ported in 1992 by Hsieh et al [20], who showed 89 cases (2.99%) of
chromosomal aberrations among their 2975 cases of amniocen-
tesis. Out of these cases, 36 has structural aberrations, however,
they did not mention about deletions. Later, Tseng et al [21] re-
ported their 10-year experience with 7028 cases of amniocentesis
and showed that chromosomal aberrations were detected in 207
cases (2.90%). The highest detection rate of chromosomal aberra-
tions was observed in cases with abnormal ultrasound ﬁndings
(8.86%). However, these two articles did not mention about chro-
mosomal deletions.
A chromosomal deletion involves the loss of a part of chro-
mosome and results in monosomy for that segment of the
chromosome. If the deleted part is very large, it will be
incompatible with survival to term of pregnancy. Any deletion
resulting in a loss of more than 2% of the total haploid genome
will be lethal [22]. Improved resolution of the conventional
cytogenetic technique increases the detection rate of chromo-
somal deletions.
The incidence of chromosome deletion is very low. In 1992, Ja-
cobs et al [23] found a prevalence of 0.014% for deletions at prenatal
diagnosis. In 2009, Forabosco et al [24] observed that overall fre-
quency of deletions was 1 out of 6800 (about 0.015%). Chang et al
[25] reported 12 cases of chromosomal deletions in their 30-year
experiences with 16,749 cases of amniocentesis, and the inci-
dence was 0.072% (about 1/1397). In our cases, the incidence of
chromosomal deletionwas 0.093% (about 1/1110). Our frequency of
deletions seems to be much higher than Jacob et al’s [23] and
Forasbosco et al’s [24] reports, but closer to Chang et al’s [25]
report. Because Chang et al’s [25] and our hospitals are the main
referral centers in Taiwan, many cases with chromosomal abnor-
mality and fetal anomalies are likely to be referred to these hos-
pitals for further evaluation and management. Therefore, it is
reasonable to have a higher frequency of detection with chromo-
somal deletions.
In Forabosco et al’s [24] article, the most frequent chromo-
somal deletion was the terminal deletion of the short arm of
chromosome 4, which was more frequent than 5p deletion.
Forrester and Merz [26] reported that the greatest proportion of
deletions involved chromosomes 22 (14.1%), chromosomes 4
(11.3%), and chromosomes 5 (11.3%), which were identiﬁed using
a birth defects registry. In, our observation, chromosomal de-
letions are more often to occur in the short arm of chromosomal
5(4 cases, 12.9%) and the long arm of chromosome 18 (4 cases,
12.9%), which were more frequent than the deletion of chromo-
some 4 (3 cases, 9.7%). According to these reports, chromosomal
deletions do not appear to affect all chromosomes equally; it
seems that deletions involving chromosomes 5 and 4 are more
common than others. Our cases showed that 18q deletion is
relatively more frequent than other chromosomes. The higher
incidence of deletion of chromosome 22 in the study of Forrester
and Merz [26] may be due to their later detection at birth, such as
DiGeorge syndrome.
In the collaborative study of Hsu et al [27], 555 cases were
diagnosed prenatally through amniocentesis as having chromo-
somemosaicism and only 17 (0.31%) had deletions with mosaicism.
In our series, four cases had chromosomal mosaicism, two involved
chromosome 5 (Cases 7 and 8), one involved chromosome 10 (Case
16), and one involved chromosome 18 (Case 26).
With regard to sex ratio, Hook et al [28] showed that the
proportion of females was greater than that of males among the
unbalanced rearrangements (both inherited and mutant),
whereas no obvious sex difference was observed among the
Table 1
Clinical data for cases with chromosomal deletions diagnosed by amniocentesis.
Case Location
of deletion
Indications for
amniocentesis
Maternal
age (y)
Gestational age
at amniocentesis
(wk)
Fetal karyotype Type of
deletion
Inheritance of
deletions
Prenatal ultrasound ﬁndings Refs
1 1p Abnormal
ultrasound
26 30 46,XX,del(1)(p31.1p32.3) Interstitial De novo Macrocephaly, prominent forehead, ventriculomegaly,
corpus callosum hypogenesis, micrognathia,
ambiguous external genitalia
[1]
2 1q Abnormal
ultrasound
28 21 46,XX,del(1)(q43) Terminal De novo Hydrocephalus, corpus callosum agenesis [2]
3 4p Abnormal
ultrasound
29 19 46,XX,del(4)(p15.1) Terminal De novo IUGR, unilateral facial cleft and a dysmorphic face
with prominent glabella, ocular hypertelorism,
a broad bridge of the nose
[3]
4 4p AMA 35 18 46,XY,del(4)(p16.1) Terminal De novo Micrognathia, hypertelorism, suspected hypospadia d
5 4q Referred 33 21 46,XX,del(4)(q12q13.2) Interstitial De novo None d
6 5p AMA 36 15 46,XX,del(5)(p13) Terminal Unknown Unknown d
7 5p AMA 37 17 mos 46,XX,del(5)
(p15.1)[12]/46,XX[15]
Terminal De novo Microcephaly, cerebellar hypoplasia. [4]
8 5p AMA 34 20 mos 46,XY,del(5)
(p15.1)[4]/46,XY[26]
Terminal Unknown None [5]
9 5p Abnormal
ultrasound
33 22 46,XY,del(5)(p15.1) Terminal De novo Microcephaly, cerebellar hypoplasia
10 6p Abnormal
ultrasound
33 20 46,XX,del(6)(p24) Terminal De novo Oligohydramnios, orofacial clefting, bilateral
multicystic kidneys, DWM
[6]
11 7q Abnormal
ultrasound
28 26 46,XY,del(7)(q33) Terminal De novo HPE d
12 7q Abnormal
maternal
serum
screening
30 21 46,XX,del(7)(q35) Terminal De novo IUGR, microcephaly, TOF, Fig. 1 [7]
13 7q Abnormal
maternal
serum
screening
29 19 46,XX,del(7)(q22.1q31.1) Interstitial De novo Unknown d
14 9p Referred 31 21 46,XX,del(9)(q24.3q24.1) Interstitial Unknown None d
15 9q Abnormal
ultrasound
31 18 46,XX,del(9)(q21.1q22.2) Interstitial De novo Increased nuchal translucency (0.66 mm) [8]
16 10q Unknown 30 Unknown mos 46,XY,del(10)
(q23.2)[–]/46,XY[–]
Terminal Unknown Unknown d
17 10q Maternal
anxiety
33 23 46,XX,del(10)
(q11.21q11.23)
Interstitial De novo None [9]
18 10q AMA 36 17 46,XY,del(10)(q11.21q21.1) Interstitial De novo None, Fig. 2 [10]
19 11q AMA 38 18 46,XX,del(11)(q24.1) Terminal De novo None [11]
20 11q Abnormal
maternal
serum
screening
31 20 46,XY,del(11)(q24.2) Terminal De novo Short femurs and humeri, overlapping
of the toes
[12]
21 11q Abnormal
ultrasound
35 20 46,XX,del(11)(q23) Terminal De novo Unilateral duplex renal system,
pyelectasis orofacial clefts
[13]
22 13q Abnormal
maternal
serum
screening
Unknown 27? 46,XX,del(13)(pter–>q21:) Terminal De novo IUGR, cardiomegaly, an occipital
encephalocoele, a calvarial defect
[14]
23 16q AMA 34 23 46,XX,del(16)( q13q22.) Interstitial De novo Prominent coronal sutures, a prominent
frontal bone, 24 shortening of the long bones
[15]
24 18q Abnormal
maternal
serum
screening
33 18 46,XX,del(18)(q22.2) Terminal De novo None [16]
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infants and fetuses with chromosomal deletions are more likely
to be females and to be associated with major structural birth
defects. Our study showed similar ﬁndings, with the female to
male sex ratio being 20:11.
In our observation, most chromosomal deletions detected at
amniocentesis were ascertained through advanced maternal age
(11/31, 35.5%), abnormal ultrasound ﬁndings (10/31, 32.25%), and
abnormal maternal serum screening (6/31, 19.6%). This observation
is different from other kinds of chromosomal abnormalities, such
as unbalanced translocation reported by Chang et al [29] and Chen
et al [30]. The report of Chang et al [29] demonstrated that
advanced maternal age is the leading indication of amniocentesis
for reciprocal translocations, as shown in many other reports.
Chen et al [30] showed that unbalanced reciprocal translocations
detected at amniocentesis are frequently associated with
abnormal ultrasound ﬁndings. However, the frequency of ascer-
tainment in chromosomal deletions seems to be directly corre-
lated with advanced maternal age and abnormal ultrasound
ﬁndings.
We expected to observe similar ascertainments or prenatal
ﬁndings at similar locations of deletions. In fact, ascertainments
differed even at the same location of deletion. Half cases with 18q
deletion and two-third with 7q deletions (Fig. 1) were detected due
to abnormal maternal serum screening result. Of the four cases
with 5p deletion, three were detected by advanced maternal age
and the remaining one by abnormal ultrasound. Three cases of
chromosome 4 deletion had three different kinds of ascertain-
ments. In our observation, the mode of ascertainment through
abnormal ultrasound ﬁndings is as frequent as that through
advanced maternal age at amniocentesis in cases with deletions.
This implies that, in addition to prenatal ultrasound, advanced
maternal age plays an important role in the prenatal diagnosis of
chromosomal deletions. However, Forabosco et al [24] determined
that most of the aneuploidies, mosaic trisomy 21, and 45,X/46,XX
were age dependent, whereas deletion was non-age dependent in
their overall study population.
In cases with prenatal structural abnormalities, ﬁndings of
prenatal ultrasound differ from different parts of deletions. Our
cases with terminal deletion of 5p (Cases 7 and 9) demonstrated
microcephaly and cerebellar hypoplasia. Cases with 10q interstitial
deletion (Cases 16e18) had negative prenatal ultrasound ﬁndings
(Fig. 2).
In our result, 23 cases (74.2%) had terminal deletions and the
other eight cases (26.7%) had interstitial-type deletions. Among the
cases of terminal deletion, 16 (16/23, 69.6%) manifested fetal
structural abnormalities on prenatal ultrasound, whereas four (4/8,
50%) accounted for interstitial deletion. The frequency of detection
of fetal structural abnormalities by prenatal ultrasound was much
higher in cases with terminal deletions (69.6%). It seems that pre-
natal ultrasound still remains an important way of detecting
chromosome deletion, especially in those cases with terminal
deletion.
In summary, we have presented the results of prenatal diag-
nosis for chromosomal deletions using amniocentesis. Chromo-
somal deletions are more likely to occur in females and are more
frequent in chromosomes 5p and 18q. Prenatal diagnosis through
amniocentesis is frequently associated with advanced maternal
age, abnormal ultrasound ﬁndings, and abnormal maternal serum
screening. The frequency of ascertainment in chromosome dele-
tion seems to be directly correlated with advanced maternal age
and abnormal ultrasound ﬁndings. In cases with terminal de-
letions, prenatal ultrasound plays an important role in prenatal
diagnosis.
Fig. 2. Case 18: karyotype 46,XY,del(10)(q11.2q21.1). Arrows indicate the breakpoints. The del(10q) chromosome is on the right of the chromosome 10 pair. This is an interstitial
deletion.
Fig. 1. Case 12: karyotype 46,XY,del(7)(q35). The arrow indicates the breakpoint. The del(7q) chromosome is on the left of the chromosome 7 pair. This is a terminal deletion.
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